Skip to main content

Table 2 CD4 lymphocytic level changes before and after treatment

From: Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients

Items CD4 lymphocytic count (mean ± SD)
Before treatment 310.60 ±89.9
End of treatment 385.90 ±108.71
SVR at 12 weeks 445.13 ±125.44
F-value 11.482
P-value 0.0001
Significance S
  1. SD standard deviation, P-value probability, S significant